People with two types of cancers who need treatment costing millions of New Taiwan dollars are now covered by the National Health Insurance (NHI) system.
From Nov. 1, people with B-cell acute lymphoblastic leukemia (B-ALL), one of the most common types of childhood cancer, or relapsed or refractory diffuse large B-cell lymphoma (DLBCL) are covered if they meet certain criteria, the National Health Insurance Administration (NHIA) announced last month.
The therapy for people with these cancers takes T cells and modifies them with chimeric antigen receptors (CARs) so that they can recognize and destroy cancer cells.
Photo: CNA
It costs about NT$8.19 million (US$253,537), said Huang Yu-wen (黃育文), director of the NHIA’s Medical Review and Pharmaceutical Benefits Division.
Given the cost, the NHIA has limited coverage to two types of cancer patients and a period of up to two years, but discussions are to be held to decide if the coverage should last longer, NHIA Director-General Shih Chung-liang (石崇良) said.
The Food and Drug Administration previously approved the use of CAR T cell therapy for all people with B-ALL aged 25 or under and for people with DLBCL whose cancers have relapsed or not responded to first or second-line treatments.
To be eligible for NHI coverage under the new program, people with B-ALL must be aged 25 or under, have leukemia that has not responded to other treatments, have relapsed after a bone marrow transplant or have had more than one relapse.
People with DLBCL are eligible for coverage if their cancer has recurred or not responded to treatments considered to be second-line or higher.
Huang Wei-han (黃威翰), deputy director of Hualien Tzu Chi Hospital’s Cell Therapy Center, said that 15 to 20 percent of young people with B-ALL have relapses, and only 30 to 50 percent of those who have relapses survive for five years.
About half of adult cases relapse, and only 10 percent of them survive for five years, he said.
Last year, a 10-year-old girl who had been battling B-ALL for more than four years became the first person in Taiwan to be successfully treated using CAR T cell therapy, Huang said.
Meanwhile, bone marrow transplants do not work for roughly half of all people with DLBCL, and those diagnosed with a cancer that has not responded to treatment or whose cancer has relapsed after a bone marrow transplant have only a 20 percent chance of surviving for two years, he said.
Huang Tai-chung (黃泰中), an attending hematology physician at National Taiwan University Hospital and secretary-general of the Hematology Society of Taiwan, said that 40 percent of people with DLBCL become completely cancer free after receiving CAR T cell treatment, while 13 percent are partially cured.
“Even if their cancer is only partially cured, it means a lot to the patients,” because it can help prepare them for the next stage of treatment, he said.
Sixty percent of people with B-ALL whose bone marrow transplants have failed can be completely cured with CAR T cell treatment, Huang Tai-chung said.
People can receive CAR T cell treatment at seven hospitals in Taiwan: National Taiwan University Hospital, National Taiwan University Cancer Center, Linkou Chang Gung Memorial Hospital, China Medical University Hospital, Taichung Veterans General Hospital, Kaohsiung Medical University Chung-Ho Memorial Hospital and Hualien Tzu Chi Hospital, Shih said.
Considering that most countries issue more than five denominations of banknotes, the central bank has decided to redesign all five denominations, the bank said as it prepares for the first major overhaul of the banknotes in more than 24 years. Central bank Governor Yang Chin-lung (楊金龍) is expected to report to the Legislative Yuan today on the bank’s operations and the redesign’s progress. The bank in a report sent to the legislature ahead of today’s meeting said it had commissioned a survey on the public’s preferences. Survey results showed that NT$100 and NT$1,000 banknotes are the most commonly used, while NT$200 and NT$2,000
The Centers for Disease Control (CDC) yesterday reported the first case of a new COVID-19 subvariant — BA.3.2 — in a 10-year-old Singaporean girl who had a fever upon arrival in Taiwan and tested positive for the disease. The girl left Taiwan on March 20 and the case did not have a direct impact on the local community, it said. The WHO added the BA.3.2 strain to its list of Variants Under Monitoring in December last year, but this was the first imported case of the COVID-19 variant in Taiwan, CDC Deputy Director-General Lin Ming-cheng (林明誠) said. The girl arrived in Taiwan on
ANNUAL EVENT: Two massive Pokemon balloons are to be set up in Daan Park, with an event zone operating from 10am to 6pm This year’s Taipei Floral Picnic is to be held at Daan Park today and tomorrow, featuring an exclusive Pokemon Go event, a themed food market, a coffee rave picnic area and stage performances, the Taipei Department of Information and Tourism said yesterday. Two massive Pokemon balloons are to be set up in the park as attractions, with an exclusive event zone operating from 10am to 6pm, it said. Participants who complete designated tasks on-site would have a chance to receive limited-edition souvenirs, it added. People could also try the newly launched game Pokemon Pokopia in the trial area, the department said. Three PokeStops are
South Korea is planning to revise its controversial electronic arrival card, a step Taiwanese officials said prompted them to hold off on planned retaliatory measures, a South Korean media report said yesterday. A Yonhap News Agency report said that the South Korean Ministry of Foreign Affairs is planning to remove the “previous departure place” and “next destination” fields from its e-arrival card system. The plan, reached after interagency consultations, is under review and aims to simplify entry procedures and align the electronic form with the paper version, a South Korean ministry official said. The fields — which appeared only on the electronic form
RSS